All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Deals, Development and Manufacturing
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
Global Perspectives
Intellectual Property & Patents
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
Mergers and Acquisitions
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Deals, Development and Manufacturing
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
Global Perspectives
Intellectual Property & Patents
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
Mergers and Acquisitions
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe
Advertisement

Drug Solutions Podcast: 2022 Bio/pharma Trends: US-Based Suppliers, Digitization, and Sustainability

January 18, 2022
By Meg Rivers
Chris Spivey
News
Podcast

In this episode of the Drug Solutions podcast, Chris Spivey, editorial director, and Meg Rivers, senior editor, interview experts on up-and-coming 2022 trends in the bio/pharma industry.

Pharmaceutical Technology presents the Drug Solutions podcast, where the editors will chat with industry experts from across the pharmaceutical and biopharmaceutical supply chain. Join us as experts share insights into your biggest questions—from the technologies, to strategies, to regulations related to the development and manufacture of drug products.

In this episode, Chris Spivey, Editorial Director, and Meg Rivers, Senior Editor, interview industry experts to discuss 2022 trends along with a few trends that emerged in 2021, specifically:

  • Biomanufacturing trends from 2021
  • The demand for US-based suppliers in 2022
  • Ensuring resources in the supply chain, including collaborations with competitors
  • Digitizing and remote work
  • Sustainability in APIs; API and drug product interface; API and excipient trends
  • Increased interest in modeling services
  • Importance of new cell therapies

Interviews featuring:

  • Peter Walters, Director of ATMP, CRB
  • Yvonne Duckworth, Automation Engineer, CRB
  • Cary Martin, VP of Marketing, August Bioservices
  • Gabe Longoria, Chief Commercial Officer, Astrea Bioseparations
  • Merrilee Whitney, Head of Biocontinuum Platform, MilliporeSigma (the Life Science business of Merck KGaA, Darmstadt, Germany)
  • Helen Anderson, Commercial Lead, USA, Aspen
  • San Kiang, CTO, Porton Pharmatech/J-Star Research
  • Anil Kane, Global Head of Technical Scientific Affairs, Pharma Services, Thermo Fisher Scientific
  • Matthias Bucerius, Head of Actives and Formulation, MilliporeSigma (the Life Science business of Merck KGaA, Darmstadt, Germany)
  • Jeff Woodhead, Senior Scientist, Simulations Plus
  • Gregory Lane, PhD, Senior Research Investigator, Bristol Myers Squibb

Listen to this podcast on SoundCloud, Spotify, Google Podcasts, or Apple Podcasts.

Recent Videos
Related Content

Insulin Vial Trapped in Ice for Diabetic Challenges | Image Credit: ©Nisit – stock.adobe.com

Parenteral Formulation: Deciding When to Go Frozen or Freeze-Dried

Cynthia A. Challener
May 8th 2025
Article

Scientific, economic, and practical factors should be considered when choosing between the frozen state and lyophilization.


Drug Solutions Podcast: Equipment Trends for Addressing Production of New Modalities

Drug Solutions Podcast: Equipment Trends for Addressing Production of New Modalities

Feliza Mirasol
March 25th 2025
Podcast

The growing development of new biotherapeutic modalities will rely heavily on automation and progressive technologies.


Image Credit: © Alessandro Grandini - stock.adobe.com

Understanding the Variability in Bioburden Test Results in Biomanufacturing

Naveenganesh Muralidharan
May 7th 2025
Article

This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.


Drug Solutions Podcast: Forecasting Pharma’s Future

Drug Solutions Podcast: Forecasting Pharma’s Future

Felicity Thomas
January 31st 2025
Podcast

This episode is a compilation of comments taken from a series of interviews where experts reveal the trends that have impacted the bio/pharma industry in 2024 and those they expect to be impactful in 2025.


White House | Image Credit: © Zack Frank - stock.adobe.com

Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing

Patrick Lavery
May 7th 2025
Article

The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space

Patrick Lavery
May 7th 2025
Article

The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.

Related Content

Insulin Vial Trapped in Ice for Diabetic Challenges | Image Credit: ©Nisit – stock.adobe.com

Parenteral Formulation: Deciding When to Go Frozen or Freeze-Dried

Cynthia A. Challener
May 8th 2025
Article

Scientific, economic, and practical factors should be considered when choosing between the frozen state and lyophilization.


Drug Solutions Podcast: Equipment Trends for Addressing Production of New Modalities

Drug Solutions Podcast: Equipment Trends for Addressing Production of New Modalities

Feliza Mirasol
March 25th 2025
Podcast

The growing development of new biotherapeutic modalities will rely heavily on automation and progressive technologies.


Image Credit: © Alessandro Grandini - stock.adobe.com

Understanding the Variability in Bioburden Test Results in Biomanufacturing

Naveenganesh Muralidharan
May 7th 2025
Article

This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.


Drug Solutions Podcast: Forecasting Pharma’s Future

Drug Solutions Podcast: Forecasting Pharma’s Future

Felicity Thomas
January 31st 2025
Podcast

This episode is a compilation of comments taken from a series of interviews where experts reveal the trends that have impacted the bio/pharma industry in 2024 and those they expect to be impactful in 2025.


White House | Image Credit: © Zack Frank - stock.adobe.com

Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing

Patrick Lavery
May 7th 2025
Article

The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space

Patrick Lavery
May 7th 2025
Article

The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.

About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.